Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial.
Saved in:
| Title: | Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial. |
|---|---|
| Authors: | Lodise TP; Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, New York., Turner NA; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Duke University, Durham, North Carolina., Hamasaki T; The Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, Maryland.; Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Rockville, Maryland., Fishbane N; The Emmes Company, Rockville, Maryland., Ghazaryan V; Division of Microbiology and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Wall A; The Emmes Company, Rockville, Maryland., Ge L; The Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, Maryland.; Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Rockville, Maryland., Wu Q; The Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, Maryland.; Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Rockville, Maryland., Zeng L; The Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, Maryland.; Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Rockville, Maryland., Riccobene T; AbbVie, Florham Park, New Jersey., Patel R; AbbVie, Florham Park, New Jersey., Zaharoff S; Duke Clinical Research Institute, Durham, North Carolina., Rappo U; Anti-Infectives, Internal Medicine, Allergan, Madison New Jersey.; Now with BiomX, Inc, Ness Ziona, Israel., Evans S; The Biostatistics Center, Milken Institute School of Public Health, George Washington University, Rockville, Maryland.; Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Rockville, Maryland., Fowler VG Jr; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Duke University, Durham, North Carolina.; Duke Clinical Research Institute, Durham, North Carolina., Chambers HF; Division of Infectious Diseases, Department of Medicine, University of California, San Francisco., Holland TL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Duke University, Durham, North Carolina.; Duke Clinical Research Institute, Durham, North Carolina. |
| Corporate Authors: | Antibacterial Resistance Leadership Group |
| Source: | JAMA network open [JAMA Netw Open] 2026 Apr 01; Vol. 9 (4), pp. e2611652. Date of Electronic Publication: 2026 Apr 01. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2026.11652 |
